Special Symposium
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Chairs
- Robert L. Coleman (The Woodlands, TX, United States of America)
- Susana Banerjee (London, United Kingdom)
How to interpret overall survival data with PARP inhibitors
Special Symposium
Why are we having this Symposium? Recent regulatory actions by FDA/EMEA regarding late-stage approval for PARPi in recurrent ovarian cancer
Lecture Time
10:15 - 10:30
Speakers
- Robert L. Coleman (The Woodlands, TX, United States of America)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
How to interpret overall survival data with PARP inhibitors
Special Symposium
Is there clinical evidence to support the link between PARPi use and a negative impact on OS?
Lecture Time
10:30 - 10:45
Speakers
- Jonathan A. Ledermann (London, United Kingdom)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
How to interpret overall survival data with PARP inhibitors
Special Symposium
Is there a biological rationale to support decremental impact on overall survival?
Lecture Time
10:45 - 11:00
Speakers
- Antonio Jose Gonzalez Martin (Madrid, Spain)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
How to interpret overall survival data with PARP inhibitors
Special Symposium
Q&A
Lecture Time
11:15 - 11:50
Speakers
- All Speakers (Barcelona, Spain)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35